SCHEMBL23917077

SCHEMBL23917077

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c3ccc3nc5ccccn5c34)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 5/20 0.40
GLA P06280 5/20 0.40
GAA P10253 5/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HPGD P15428 3/20 0.36
HSD17B10 Q99714 3/20 0.36
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
NPC1 O15118 4/20 0.35
RAB9A P51151 3/20 0.35
PDE5A O76074 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPT P10636 1/20 0.34
TP53 P04637 1/20 0.33
MAPK10 P53779 1/20 0.33
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
AKT1 P31749 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23917102 0.88 ALDH1A1 (0.42) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917358 0.88 ACP1 (0.41) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917312 0.85 KDM4E (0.41) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917374 0.84 KDM4E (0.37) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917140 0.83 KDM4E (0.36) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917406 0.81 KDM4E (0.36) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL23917409 0.80 KDM4E (0.34) KDM4EALDH1A1GLAGAASMN1; SMN2
SCHEMBL10027613 0.79 L3MBTL1 (0.41) KDM4EALDH1A1HPGDPOLBNPSR1
SCHEMBL12691199 0.78 L3MBTL1 (0.40) KDM4EALDH1A1HPGDPOLBNPSR1
SCHEMBL23917320 0.78 KDM4E (0.46) KDM4EALDH1A1GLAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11581497-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-02-14 US disclosed
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11581497-B2 Materials for organic electroluminescent devices OR10J3, EPCAM, L1CAM KDM4E 2132/4885ALDH1A1 504/4885GLA 1843/4885
US-20210320264-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES OR10J3, EPCAM, L1CAM KDM4E 2132/4885ALDH1A1 504/4885GLA 1843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.